chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a company representative refers to a patient of unknown age with shingles. On an unknown date the patient was vaccinated with ZOSTAVAX. On an unknown date the patient experienced shingles. The outcome of shingles was reported as recovering/resolving. Additional information is not expected.
Red warm rash around injection site approximately 1 week after injection. Rash has spread around injection site and to lower upper arm just above elbow during the second week after vaccination
I was resting watching TV and it was like a light switch was turned on. My ears started ringing really loud and is constant and has not stopped. I also had a similar reaction to the 2nd covid shot and my ears have not stopped ringing from that time in march. it is that the ears are ringing even louder.  That was reported to VAERS on 4/8/2021, e-report number 418880.
5 y/o received her kindergarten vaccines. She reacted to KINRIX & MMR 6 1/2 x 5 1/4 induration warm and red.
Stabbing pain in right armpit Swelling in right armpit Seems like fluid, NOT a lymph node - covers all of armpit
Fever peaking at 101.1 degrees. Irritability. Given Acetomenophen drops.
Systemic: Bell's Palsy-Medium, Additional Details: Patient called to report the adverse reaction on the day his second dose would have been given (10/07/2022). He said he went to the emergency room and had recieved treatment. I advised him against getting the second dose, according to the patient he is almost completely recovered, I adviced that we would call in a wekk to follow up on his recovery.
Knot in right arm the size of a pin pong with occasional pain that started 3/19/22. has some redness but not hot to touch
Breakthrough Covid-19 infection: at least 5 symptoms including high grade fever; Breakthrough Covid-19 infection: at least 5 symptoms including high grade fever; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient. A 24-year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), intramuscular, administered in arm left, administration date 28May2021 17:00 (Batch/Lot number: unknown) at the age of 24 years as dose 2, single and intramuscular, administration date 07May2021 17:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported that the patient had breakthrough Covid-19 infection at least 5 symptoms including high grade fever (medically significant) with onset of 03Jan2022 at 20:00 and outcome of recovering. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (08Jan2022) positive, notes: Nasal Swab (NAAT). Therapeutic measures were not taken as a result of drug ineffective, covid-19. Additional information: the patient did not receive other vaccines in the last four weeks. The patient was not diagnosed with covid-19 prior to vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
pt recv vax;approx 13 days later,pt erupted in extensive impetiginous varicella;lesions were greater than 50 & cont to erupt for another wk or so;incidentally pt's brother subsequently devel varicella;
Rash at the site of injection 1 week after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE RASH. At the time of the report, VACCINATION SITE RASH had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Reporter did not allow further contact
8cm x 5cm area of swelling on lt leg around inj site 1 day p/vax;
Left thyroid gland slightly swollen about 3 days after first vaccination and continues after second shot; Hard swelling below injection site on left lateral upper arm approximately 3inches long by 1/2-inch-wide, starting 11 1/2 hours after first vaccination (with pain) It lasted about two days; Hard swelling below injection site on left lateral upper arm approximately 3inches long by 1/2-inch-wide, starting 11 1/2 hours after first vaccination (with pain) It lasted about two days; Continuous upper arms muscle pain when raise arms overhead since day after both shots , which lasted 3 weeks after 1st shot; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Mar2021 10:30 (Batch/Lot number: unknown) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "sulfa antibiotics allergy" (unspecified if ongoing). Concomitant medication(s) included: ARMOUR THYROID. The following information was reported: PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 26Mar2021 23:00, outcome "recovered" (28Mar2021 23:00) and all described as "Hard swelling below injection site on left lateral upper arm approximately 3inches long by 1/2-inch-wide, starting 11 1/2 hours after first vaccination (with pain) It lasted about two days"; MYALGIA (non-serious) with onset 26Mar2021 23:00, outcome "recovered" (Apr2021), described as "Continuous upper arms muscle pain when raise arms overhead since day after both shots , which lasted 3 weeks after 1st shot"; GOITRE (non-serious) with onset 29Mar2021, outcome "not recovered", described as "Left thyroid gland slightly swollen about 3 days after first vaccination and continues after second shot". Therapeutic measures were not taken as a result of peripheral swelling, pain in extremity, myalgia, goitre.  Additional Information: The vaccine was administered in a Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Body aches; Chills; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (Body aches) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MYALGIA (Body aches) and CHILLS (Chills).        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-024583, MOD-2021-024588 (E2B Linked Report).   Reporter did not allow further contact.  Lab parameters were not provided .   No other reactions reported.   Action taken with mRNA-1273 in response to the event was not provided.; Sender's Comments:  MOD-2021-024583:Same reporter MOD-2021-024588:Same reporter
Covid; Initial Report Received on 08-Mar-2023  A pharmacist reported that a male patient (age, race, and ethnicity unknown) received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and had COVID.   Medical history, allergies, and concomitant medications were not reported at the time of vaccination.  On an unknown date in November, the patient received the first dose of HEPLISAV-B vaccine (Lot #, expiration date, NDC #, route, and injection site were unknown) and had COVID since. The patient wanted to receive his second dose of HEPLISAV-B now.    No further information was available.  Company Comment:  The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Booster dose of Moderna COVID-19 vaccine administered by RN  to 16 year old, who received Pfizer vaccine as a primary.   As of 12/22/2021 Mr.  has reported no adverse effects.
Pt states approx 10:30 AM, 15-30 min after vaccine given, pt noticed "pounding heartbeats, fast HR, flushed face, SOB. Got better then worsened. Called 911 - ER visit EKG - ST 150-170 ? SVT. LOPRESSOR recently d/c'd. 2 doses Adenosine without effect. HR decreased to 80s by 1 PM.
Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration.
Bell's palsy; Patient received his first Pfizer of vaccine on 26Feb2021, follow up on 28Jun2021 to see if the patient should get the 2nd vaccine; This is a spontaneous report from a contactable Other HCP via Medical Information Team. A 69-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as dose number unknown single (at the age of 69-years-old) for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6202) intramuscularly in left arm on 26Feb2021 17:45 as dose 1, single for COVID-19 immunization. Patient experienced facial muscle weakness and Bells Palsy after the first dose of vaccination. Reporter stated she was calling from a physician office on behalf of a patient who had an adverse reaction to the vaccine. She stated she was calling to follow up as they have not heard back and neither has the patient. She stated that they received it 19Mar2021 and filled it out shortly after that and faxed it. States she is not sure if this was called in and reported or by who. States it was before she started working there and she first saw this when the form came to fill out regarding this. She was a medical assistant. She was calling on behalf of a patient who received his first Pfizer Covid vaccine dose on 26Feb2021. On 01Mar2021, his MDs office for side effects and was diagnosed with Bells Palsy. She stated patient reported this to DSU at that time but did not receive a follow up call. She wanted to know if the patient is ok to receive his second dose of the Pfizer vaccine. Unable to obtain patients age because she disconnected during hold while agent was researching information. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
red sore lump initially .  Followed by red itchy patch approx 3x4 inches, Took Benydril. Currently, 2 weeks in, red patch has moved forward on the arm and rash has appeared on chest with dappled red spots on arms and thighs. Also my face is swollen .
severe nausea; Feeling lethargic; Sick every 20 minutes/sick feeling; Felt like throwing up not much came up; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Feeling lethargic), ILLNESS (Sick every 20 minutes/sick feeling), NAUSEA (severe nausea) and VOMITING (Felt like throwing up not much came up) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 02DB21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN and AMLODIPINE for Blood pressure management.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021 at 9:25 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VOMITING (Felt like throwing up not much came up). On 29-Apr-2021 at 4:00 PM, the patient experienced LETHARGY (Feeling lethargic) and ILLNESS (Sick every 20 minutes/sick feeling). On 29-Apr-2021 at 5:00 PM, the patient experienced NAUSEA (severe nausea). On 30-Apr-2021, NAUSEA (severe nausea) and VOMITING (Felt like throwing up not much came up) had resolved. At the time of the report, LETHARGY (Feeling lethargic) and ILLNESS (Sick every 20 minutes/sick feeling) outcome was unknown.            It was reported that the patient drank lot of water prior to the vaccine.Patient was not able to take medication hence drank ginger tea drank all the day. Patient had Blood Pressure. Patient had no allergies.Patient not had COVID or tested Positive for COVID No treatment medication was reported.  Patient's experience feared to get booster dose. Nausea was started around 10-11 pm  non stop every 15-20 min. This went on until the following day around 5:00 and started to dissipate.Patient had 17 hour severe nausea.Felt like throwing up not much came up   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: Follow up received contains start date of first dose and second dose, batch number, start date of event, patient details (age) and concomitant medication of the patient. On 01-Feb-2022: Reporter details updated.Patient demographics updated.Medical History,Concomitant product information was added.Anatomical Location was updated.Events were added.Outcome of Event was updated
Experienced right arm tingling and the tingling went up into the right side of her neck.  Experienced a few minutes of chills and heart racing.
On 10/02/2000 the patient presented with an outbreak of 34 pox. Unspecified medical attention was sought. Follow up information from a RN indicated that she did not consider the patient's experience an adverse experience.
pt recv vax;inc T 104;frequent cough;lt deltoid red,warm to touch;to MD & started on cefyil;dx of severe tonsillitis;
COVID-19 symptoms started on 06/27/2022; tested positive on 06/28/2022. Symptoms came on very suddenly and I felt like my entire body including my hair and fingers hurt and everything just hurt. Shortly after that, I spiked a 100.5 fever and then I went to sleep and the next day I noticed a massive rash on my left breast. I had a discussion with my dermatologist who told me I had shingles again, so I had COVID-19 and Shingles at the same time. Symptoms lasted 5 days or so and I went back for repeat PCR that Sunday 07/03/2022 and it came back negative. The rash was still there but the intense pain and stinging of it subsided each day. 07/20/2022 I went to sleep and the fatigue came back around midnight or so and I woke up not feeling good and took a rapid test and tested positive again as well as positive on PCR. The doctor office said if I didn't feel good I should just stay home. I was sickly with sinus issues, runny nose, coughing, fatigue, and a headache that was the worse thing about it and lasted an entire week. I finally tested negative on Monday 08/01/22.
Itching, inflamed, red patch below injection site upper right arm.   Treated with Triamcinolone Steroid Ointment,. Ice, Benedryl.  Slowly spread to about a 5 inch square section below the site.  Started day 2 after injection.    Continued for 14 days.   Improved with treatment.    Was treated for "infection" after first injection with DoxyCYCLINE Hyclate..   Symptoms were less severe and did not appear for 10 days after the first injection.  This was not reported at the time.  Due to the delay in the onset of symptoms   (10 days) it was not diagnosed as Covid Arm.
Pt called the store on 11/12/08 to report reaction to a PNEUMOVAX vaccination on Monday 11/10/08. Red, hot inflamed area on left arm by axilla (size of a plum), Fever. Went to ER & personal physician on 11/12/08.
Information has been received from a registered nurse concerning a 25 year old female patient with no medical history or drug allergies who on 15-JUN-2007, was vaccinated with a first dose of Gardasil (Lot 3 658094/0524U). There was no concomitant medication. On 20-JUN-2007, the patient experienced arm swelling, joint pain, soreness and achiness. It was reported that after the pain continued for about 5 days, she decided to contact her physician's office. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. "About a week later," the patient recovered from joint pain, soreness and achiness and the outcome of her swelled arm was unknown. No product quality complaint was involved. Additional information has been requested.
Fever; Chills; Injection site rash; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and INJECTION SITE RASH (Injection site rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Allergy.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and INJECTION SITE RASH (Injection site rash). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and INJECTION SITE RASH (Injection site rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  No relevant concomitant medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-079093 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079093:
'problems with her legs'; Legs were hurting; feet were burning; This is a spontaneous report from a contactable consumer (patient herself). A 61-year-old female patient received BNT162B2 (BNT162B2, Solution for injection, Lot number and expiration date: not reported), via an unspecified route of administration on 10Sep2021 as DOSE 2, SINGLE (age at vaccination 61-year-old) for covid-19 immunisation. The patient medical history was not reported as none. The patient's had no concomitant medications. The patient historical vaccine includes BNT162B2 (BNT162B2, Solution for injection, Lot number and expiration date: not reported), via an unspecified route of administration on 10Sep2021 as DOSE 1, SINGLE (age at vaccination 61-year-old) for covid-19 immunisation and had pain. It was reported that On her 2nd dose, she experienced leg pain within 24 hours - Legs were hurting, feet were burning and really had bad pain, she had to massage to ease the pain, it is hard to sleep and never had this before She did not take any pain medication or any other drugs in the past, Asking if has anybody reported like leg pain after getting the shot of the Pfizer COVID 19 vaccine. The outcome of the events was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Patient states she had a rash, swelling and pain at the injection site for 3 to 4 days after vaccination.
Administration site became red & swollen 7 days after administration (area apx 60 mm X 120 mm)
Very high tempeatures 103 & 104, shaking at some times. Been giving Tylenol & Motrin for fever but not helping. Almost 48hrs later & still has these temps.
Fever; Chills; Her legs got extremely sore/Legs got so sore; both legs; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 82-year-old female patient received bnt162b2 first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER2613), dose 1 via an unspecified route of administration, administered in right arm on 21Mar2021 at 12:00 (at the age of 81-year-old) as 1st dose, single dose for covid-19 immunisation. Medical history included ongoing high blood pressure (Diagnosed a long time ago), Crippled leg from an unknown date and unknown if ongoing (she is dragging one and trying to walk on the other one and she can't hardly get around on it), eyesight is not that good from an unknown date and unknown if ongoing (she can't see that well), ongoing pain in a disc in her back from an unknown date and unknown if ongoing. Concomitant medication(s) included tramadol (MANUFACTURER UNKNOWN) taken for pain in a disc in her back from an unspecified start date and ongoing at a dose of 50mg twice a day; gabapentin (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unspecified start date and ongoing at a dose of 300mg twice a day; lorazepam (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unspecified start date and ongoing at a dose of 2mg once a day at night; nifedipine (MANUFACTURER UNKNOWN) taken for blood pressure increased from an unspecified start date and ongoing at a dose of 60mg once a day. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient previously took IV iron for the indication of iron falls low; Furosemide and experienced cramp (Dose: 20mg, she is also on a water pill, Furosemide but it was not taken in the two weeks). The patient experienced Her legs got extremely sore/Legs got so sore; both legs, fever and chills. Fever and chills lasted only one day but is still experiencing sore legs but it has it improved slightly. It was reported that it hurts to get up, she already has a crippled leg, she is dragging one and trying to walk on the other one and she can't hardly get around on it. Caller clarifies it hurts from her butt down on her legs. The reporter states she can't take aspirin, codeine, penicillin or could not have strawberries. The patient did not visit emergency room or physician office. The outcome of the events Her legs got extremely sore/Legs got so sore; both legs was recovering while for fever and chills was recovered on 21Mar2021.  No follow-up attempts are needed. No further information is expected.
Arm swelling; sore; swollen; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 55-year-old female patient (no pregnancy) received first dose of bnt162b2, intramuscularly at site of left arm at 11:15 on 18Dec2020 at single dose for COVID-19 immunization. Medical history included atrophied kidney, high BP, high cholesterol and allergies to medications, food, or other products. Concomitant medication included atorvastatin calcium (LIPITOR) and benazepril hydrochloride (LOTENSIN). The patient experienced arm swelling, sore, and swollen at 18:00 on 18Dec2020. No treatment received for events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was not recovered.  Information on the Batch/Lot number has been requested.